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OBJECTIVES To evaluate immunohistochemically various parameters of inflammation in coronary atherec-
tomy specimens obtained from restenotic culprit lesions of patients presenting with either
stable or unstable angina (UA).
BACKGROUND There is no information regarding the relationship between atherosclerotic plaque inflam-
mation and the severity of the coronary syndromes in patients with restenotic coronary
lesions.
METHODS A total of 37 patients with either stable angina or UA underwent directional coronary
atherectomy for restenotic coronary lesions. Cryostat sections of atherectomy specimen were
immunohistochemically stained with monoclonal antibodies CD68 (macrophages [MACs]),
CD3 (T-lymphocytes) and alpha-actin (smooth muscle cells [SMCs]). Smooth muscle cell
contents and MAC contents were planimetrically quantified as the percentage immunopo-
sitive tissue area of the total tissue area. T-lymphocytes were counted at 100-3 magnification
throughout the entire section and expressed as number of cells per mm2.
RESULTS Restenotic coronary lesions of patients with UA or stable angina showed no significant
difference in SMC areas (31.9% 6 16.3% vs. 38.5% 6 18.8%, respectively; p 5 NS).
However, restenotic coronary lesions of patients presenting with unstable angina contained
significantly more MACs (24.4% 6 15.1% vs. 10.5% 6 5.8%, p 5 0.001) and T-lymphocytes
(18.8 cells/mm2 6 15.1 cells/mm2 vs. 8.6 cells/mm2 6 9.8 cells/mm2; p 5 0.034) than
patients with stable angina.
CONCLUSIONS These results suggested that inflammation appears to affect plaque instability in restenotic
coronary lesions resulting in unstable coronary syndromes. (J Am Coll Cardiol 2000;35:
963–7) © 2000 by the American College of Cardiology
Studies evaluating atherosclerotic plaque specimens re-
trieved by directional coronary atherectomy (DCA) have
demonstrated differences in the extent of plaque inflamma-
tion between patients with stable and unstable angina (UA)
(1–3). These studies provided further support to the con-
tention that infiltration of macrophages (MACs) is crucial
for the onset of unstable coronary syndromes (4–6). Thus
far, these clinicopathologic relations between the type of
angina and the extent of inflammation in culprit lesions are
derived from patients with de novo lesions. Recent literature
suggests an association between infiltrated plaque MACs
and the development of restenosis after DCA (7). Tissues of
patients with a restenotic lesion as their culprit have not
been studied from this point of view. The aim of the study
was to evaluate the relationship between the presence of
inflammatory cells in restenotic lesions and the types of
evolving ischemic coronary syndromes.
METHODS
Patient population. A total of 37 patients with a restenotic
culprit lesion that was suitable for DCA were included. The
patient cohort consisted of 18 patients with chronic stable
angina, classes 1–3 according to the Canadian Cardiovas-
cular Society (CCS) classification (8) and 19 patients with
UA, classes I–III according to Braunwald’s classification (9).
Immunohistochemistry. Immediately after the DCA
procedure, the obtained tissue fragments were carefully
oriented in embedding fluid (Tissue Tek; Sakura Finitek
Europe BV, Zoeterwoude, The Netherlands) in such a
way that the sites with the largest surface area were in the
plane of cutting the sections. Thereafter, they were
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frozen in liquid nitrogen and stored at 280°C. Frozen
sections were cut at 5 mm, one section was stained with
hematoxylin-eosin for morphologic evaluation and adja-
cent serial sections were mounted for immunohistochem-
istry. The primary monoclonal antibodies used were
anti-CD68 (Dakopatts, Glostrup, Denmark) for the
detection of macrophages (MACs), anti-CD3 (Beckton
and Dickinson, Mountain View, California) for the
detection of T-lymphocytes and anti alpha-actin
(SMA-1, Dakopatts, Glostrup, Denmark) for the detec-
tion of smooth muscle cells (SMCs). In both cases a
three-step indirect peroxidase method was used as previ-
ously described (10), and antibody complexes were visu-
alized by 3-amino-ethylcarbazole. No counter stain was
used.
Morphometric analysis. Results of anti-CD 68, anti-CD3
and anti-alpha-actin immunostaining were planimetrically
quantified using image analysis software on a personal
computer connected with a video-mounted microscope.
The total tissue area of the immunostained sections of each
atherectomy specimen was outlined manually on the video
screen and measured. The tissue areas of the immuno-
stained sections, which were occupied by immunopositive
stained cells (MACs or SMCs), were measured automati-
cally using gray scale detection with a fixed threshold.
Thereafter, the SMC and MAC areas were calculated as
percentages of the total tissue area. T-lymphocytes were
counted at 100-3 magnification throughout the entire
section and expressed as number of cells per mm2. The
pathologists were blinded to the results of the clinical
classification of anginal symptoms.
Statistical analysis. Data are expressed as mean 6 SD. For
comparison of clinical, angiographical and immunohisto-
chemical data, an unpaired Student t test was used for
continuous data and a chi-square test for categorical data. A
Mann-Whitney U test was performed for nonparametric
continuous data and a Fisher’s exact test for categorical data.
We used multivariate linear regression to adjust differences
in SMC, MAC and T-lymphocytes between patients with
stable and unstable angina for difference in baseline char-
acteristics between these patients groups. The SPSS pack-
age for Windows version 9.0 (SPSS Inc. 1999, Arlington,
Virginia) was applied for these purposes. Values of p , 0.05
were considered statistically significant.
RESULTS
Patient population. Clinical and angiographical character-
istics of the study patients are shown in Tables 1 and 2.
Patients with UA were significantly older than patients with
stable angina (p 5 0.02); otherwise, the patient populations
were comparable.
Quantitative immunohistochemistry. Inflammatory cells,
MACs (anti-CD68) and T-lymphocytes (anti-CD3) were
found in the specimen of all patients but in highly variable
amounts. Moreover, their tissue localization showed two
Abbreviations and Acronyms
CCS 5 Canadian Cardiovascular Society
DCA 5 directional coronary atherectomy
MAC(s) 5 macrophage(s)
SMC(s) 5 smooth muscle cell(s)
REF 5 reference diameter
UA 5 unstable angina
Table 1. Clinical Characteristics of Patients With Restenotic
Coronary Lesions
Stable Angina
n 5 18 (%)
UA
n 5 19 (%)
Age (yr 6 SD) 56.1 6 13.4 65.2 6 8.2*
Men 17 (94%) 13 (68%)
Risk factors
Hypercholesterolemia 9 (50%) 7 (37%)
Hypertension 8 (44%) 12 (63%)
Diabetes mellitus 0 2 (11%)
Family history 9 (50%) 9 (47%)
Cigarette smoking 9 (50%) 4 (21%)
Medication
Beta-blocker 16 (89%) 13 (79%)
Nitrate 15 (83%) 18 (95%)
Calcium antagonist 16 (89%) 17 (89%)
Aspirin 17 (94%) 18 (95%)
Unstable angina at first PTCA 7 (39%) 9 (47%)
First intervention balloon PTCA 17 (94%) 17 (89%)
Time to restenosis (months 6 SD) 8.7 6 14.3 7.2 6 5.4
*p , 0.05 (unpaired Student t test).
PTCA 5 percutaneous transluminal coronary angioplasty; UA 5 unstable angina.
Table 2. Angiographical Characteristics of Patients With
Restenotic Coronary Lesions
Stable Angina
n 5 18
UA
n 5 19
Coronary vessel
RCA 1 (6%) 1 (5%)
LAD 14 (78%) 16 (84%)
LCX 3 (17%) 2 (11%)
Coronary lesion classification
ACC/AHA class A 2 (11%) 3 (18%)
B I 2 (11%) 6 (32%)
B II 14 (78%) 10 (53%)
Multivessel disease 2 (11%) 4 (21%)
QCA
DS (% 6 SD) 70 6 11 72 6 8
MLD (mm 6 SD) 0.97 6 0.41 1.00 6 0.33
REF (mm 6 SD) 3.20 6 0.63 3.53 6 0.36
ACC/AHA 5 classification according to the criteria of the American College of
Cardiology and the American Heart Association (22); DS 5 percent diameter
stenosis; LAD 5 left anterior descending artery; LCX 5 left circumflex artery;
MLD 5 minimal lumen diameter; QCA 5 quantitative coronary angiography; RCA
5 right coronary artery; REF 5 reference diameter; UA 5 unstable angina.
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distinct patterns. First, the inflammatory cells could be
observed scattered or in small clusters in tissue fragments
imposed of loosely arranged myxoid tissue also containing
large amounts of alpha-actin positive SMC (“neointimal
tissue”). Second, they were present in atheromatous tissue
fragments as tight infiltrates. In this type of tissue, the
CD68-positive MACs often had a foam cell appearance. A
representative example of this feature is shown in Figures
1–3.
Quantitative immunohistochemistry of restenotic coro-
nary lesions of patients with unstable or stable angina
showed no significant difference in SMC areas (31.9% 6
16.3% vs. 38.5% 6 18.8%, respectively; p 5 NS). However,
restenotic coronary lesions of patients presenting with UA
contained significantly more MACs (24.4% 6 15.1% vs.
10.5% 6 5.8%, p 5 0.001) and T-lymphocytes (18.8
cells/mm2 6 15.1 cells/mm2 vs. 8.6 cells/mm2 6 9.8
cells/mm2; p 5 0.034) than patients with stable angina (Fig.
4). We corrected these differences for the uneven age
distribution between patients with stable and UA. This
correction did not influence the observed differences.
DISCUSSION
The results of this study demonstrated that there is a
positive association between the clinical manifestation of
coronary syndromes and the extent of inflammation (MAC
and T-lymphocytes) in atherectomy specimens of patients
with a restenotic lesion. This association could not be
statistically attributed to the age difference between patients
with stable and UA.
A study by Moreno et al. (1) on atherectomy specimens
obtained from de novo lesions revealed that MAC infiltra-
tion of plaque tissue represents a marker for plaque insta-
Figure 1. Part of an atherectomy specimen derived from a restenotic culprit coronary lesion of a patient with unstable angina, H&E
(haematoxylin & eosin) stained frozen section. a: overview, boxed areas are shown in b and c. b: detail of hypercellular myxoid area showing
stellate-shaped cells amidst abundant extracellular matrix. c. Detail of atheromatous tissue showing a rim of mononuclear cells near to
atheroma (upper part). Magnification 22.53, reduced by 70% (a) and 172.53, reduced by 70% (b,c).
Figure 2. Serial section adjacent to Figure 1, immunostained with anti-alpha-SMC actin. b: detail of myxoid tissue showing a large
amount of young stellate SMCs. c: detail of atheromatous tissue containing only a few SMCs. Magnification 22.53 (a) and 172.53 (b,c).
SMC 5 smooth muscle cell.
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bility. Subsequent studies of atherectomy specimens con-
firmed the relationship between plaque instability and
unstable coronary syndromes by demonstrating increased
amounts of T-lymphocytes and expression of human leu-
kocyte antigen-DR molecules on cells (3), MACs produc-
ing the proteolytic enzyme gelatinase B (11) and MACs
producing the thrombosis initiator tissue factor (12). In
contrast, there is no information in the literature regarding
the role of inflammation in restenotic coronary lesions.
Thus far, clinicopathological studies, evaluating tissue spec-
imens obtained by DCA, revealed SMC proliferation with
concomitant extracellular matrix synthesis and marked ex-
pression of growth factors as principal features of restenotic
lesions (2,12–16). The principal role of SMCs is in accor-
dance with autopsy based studies, demonstrating the local
wall response to mechanical injury after percutaneous cor-
onary interventions (17–19). Indeed, it has been postulated
that massive SMC proliferation with abundant extracellular
matrix production could give rise to plaque expansions,
which eventually could lead to symptoms of UA (13,15).
This concept was based on similarities in SMC proliferation
and the expression of the SMC growth factors aFGF and
bFGF between lesions of patients with UA and patients
with restenotic coronary lesions. Moreover, Chen et al. (15)
found a similar phenotypic modulation of SMCs in patients
with UA and postangioplasty restenosis using transmission
electron microscopy. However, these patients with resten-
osis were not divided in the subgroups of stable and UA.
More recent insight suggests that excessive SMC growth
results in a preference for presentation of stable, rather than
a presentation of unstable, coronary syndromes (20,21). Be
that as it may, the fact remains that this study showed no
relationship between the content of SMCs and the clinical
presentation of anginal symptoms. Moreover, none of the
previous reports quantified MAC density as a marker of
plaque inflammation in patients with stable or UA as part of
their restenosis. Our finding of large concentrations of
inflammatory cells in atheromatous tissue and relatively
small amounts in the classical type restenosis tissue sug-
gested that the inflammatory activity results from preexist-
ing plaque at the site of restenosis (plaque burden). One
could hypothesize that these inflammatory cells destabilize
the tissue of restenotic coronary lesions in a similar way as
has been described for unstable primary coronary lesions.
In conclusion, our findings suggest that plaque instability
relates to inflammation rather than to the extent of SMC
proliferation. This observation provides a novel insight into
pathophysiology of restenosis supporting the contention that
plaque inflammation is pivotal in destabilization of restenotic
coronary lesions resulting in unstable coronary syndromes.
Figure 3. Serial section adjacent to Figure 1, immunostained with anti-CD 68. Figure 3a: overview. b: detail of myxoid tissue showing
low numbers of diffusely spread small MACs. c: detail of atheromatous tissue showing rim of closely packed immunostained MACs.
Magnification 22.53, reduced by 70% (a) and 172.53, reduced by 70% (b,c). MAC(s) 5 macrophage(s).
Figure 4. Percentages of immunostained smooth muscle cell areas
and macrophage areas and number of T-lymphocytes/mm2 in
restenotic coronary lesions underlying stable angina (CCS 1–3)
and unstable angina (Braunwald I–III). Data are expressed as
mean 6 SD. CCS 5 Canadian Cardiovascular Society. Open
bar 5 stable angina; closed bar 5 unstable angina.
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Study limitations. This study suggested that inflammation
of restenotic lesions and, hence, its clinical expression relates
to pre-existent de novo atherosclerotic plaque tissue before
intervention. However, it cannot be excluded that the
atheromatous tissue with inflammatory cells has developed
after the interventional procedure, particularly not in pa-
tients with a long time interval between the initial interven-
tion and the atherectomy procedure. Nevertheless, this
limitation does not alter the conclusion regarding the
positive association between the extent of MAC infiltration
in restenotic coronary lesions and its clinical presentation.
Acknowledgments
The authors acknowledge the expert statistical assistance of
Jan G. P. Tijssen (PhD, Department of Clinical Epidemi-
ology and Biostatistics) and the skilled assistance of the
technical and nursing staff of the Cardiac Catheterization
Laboratory (chief: M. Meesterman).
Reprint requests and correspondence: Dr. Jan J. Piek, Depart-
ment of Cardiology, B2-108, Academic Medical Center, Univer-
sity of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam,
Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. E-mail:
j.j.piek@amc.uva.nl.
REFERENCES
1. Moreno PR, Falk E, Palacios IF, et al. Macrophage infiltration in
acute coronary syndromes. Implications for plaque rupture. Circulation
1994;90:775–8.
2. Arbustini E, De Servi S, Bramucci E, et al. Comparison of coronary
lesions obtained by directional coronary atherectomy in unstable
angina, stable angina and restenosis after either atherectomy or
angioplasty. Am J Cardiol 1995;75:675–82.
3. van der Wal AC, Becker AE, Koch KT, et al. Clinically stable angina
pectoris is not necessarily associated with histologically stable athero-
sclerotic plaques. Heart 1996;76:312–6.
4. Davies MJ, Richardson PD, Woolf N, et al. Risk of thrombosis in
human atherosclerotic plaques: role of extracellular lipid, macrophage
and smooth muscle cell content. Br Heart J 1993;69:377–81.
5. van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of
intimal rupture or erosion of thrombosed coronary atherosclerotic
plaques is characterized by an inflammatory process irrespective of the
dominant plaque morphology. Circulation 1994;89:36–44.
6. Libby P. Molecular bases of the acute coronary syndromes. Circulation
1996;91:2844–50.
7. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al. Macrophage
infiltration predicts restenosis after coronary intervention in patients
with unstable angina. Circulation 1996;94:3098–102.
8. Campeau L. Grading of angina pectoris. Circulation 1976;54:522–33.
9. Braunwald E. Unstable angina: a classification. Circulation 1989;80:
410–4.
10. van der Loos CM, Das PK, van den Oord JJ, Houthoff HJ. Multiple
immunoenzyme staining techniques. Use of fluoresceinated, biotinyl-
ated and unlabelled monoclonal antibodies. J Immun Meth 1989;117:
45–52.
11. Brown DL, Hibbs MS, Kearney M, et al. Identification of 92-kD
gelatinase in human coronary atherosclerotic lesions. Association of
active enzyme synthesis with unstable angina. Circulation 1995;91:
2125–31.
12. Moreno PR, Bernardi VH, Lopez-Cuellar J, et al. Macrophages,
smooth muscle cells and tissue factor in unstable angina. Implications
for cell-mediated thrombogenicity in acute coronary syndromes. Cir-
culation 1996;94:3090–7.
13. Flugelman MY, Virmani R, Correa R, et al. Smooth muscle cell
abundance and fibroblast growth factors in coronary lesions of patients
with nonfatal unstable angina. A clue to the mechanism of transfor-
mation from the stable to the unstable clinical state. Circulation
1993;88:2493–500.
14. Nikol S, Isner JM, Pickering JG, et al. Expression of transforming
growth factor-beta 1 is increased in human vascular restenosis lesions.
J Clin Invest 1992;90:1582–92.
15. Chen YH, Chen YL, Lin SJ, et al. Electron microscopic studies of
phenotypic modulation of smooth muscle cells in coronary arteries of
patients with unstable angina pectoris and postangioplasty restenosis.
Circulation 1997;95:1169–75.
16. Taylor JA, Farb AA, Angello DA, et al. Proliferative activity in
coronary atherectomy tissue. Clinical, histopathologic and immuno-
histochemical correlates. Chest 1995;108:815–20.
17. Essed CE, van den Brand M, Becker AE. Transluminal coronary
angioplasty and early restenosis. Fibrocellular occlusion after wall
laceration. Br Heart J 1983;49:393–6.
18. Ueda M, Becker AE, Fujimoto T. Pathological changes induced by
repeated percutaneous transluminal coronary angioplasty. Br Heart J
1987;58:635–43.
19. Glagov S. Intimal hyperplasia, vascular modeling and the restenosis
problem. Circulation 1994;89:2888–91.
20. Weissberg PL, Clesham GJ, Bennett MR. Is vascular smooth muscle
cell proliferation beneficial? Lancet 1996;347:305–7.
21. Lafont A, Libby P. The smooth muscle cell: sinner or saint in
restenosis and the acute coronary syndromes? J Am Coll Cardiol
1998;32:283–5.
22. Ryan TJ, Faxon DP, Gunnar RP, and the ACC/AHA Task Force.
Guidelines for percutaneous transluminal angioplasty. J Am Coll
Cardiol 1988;12:529–45.
967JACC Vol. 35, No. 4, 2000 Piek et al.
March 15, 2000:963–7 Inflammation in Restenotic Lesions
